Please assess the completion status of the following clinical trial:

Trial Title: Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Must meet 1 of the following criteria:~* Diagnosis of non-small cell lung cancer by CT scan, bone scan, or biopsy~  * Stage III or IV disease~ * Clinically assessed with~* Healthy participant~Exclusion Criteria:

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- fluorine F 18 FEQA + positron emission tomography (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).